HIV Disease in Women and Children
A special issue on prevention and treatment of pregnant women and their offspring
We have learned a lot about how to prevent transmission of HIV from mother to their infants, and the time to act is now
CATHERINE M. WILFERT, M.D.
OPTIMAL MEDICAL MANAGEMENT
Treatment reduces the likelihood of vertical transmission as well as maternal disease progression
BONNIE J. DATTEL, M.D.
Combinations of reverse transcriptase inhibitors in children: A small study shows ZDV plus 3TC to be effective in patients who fail monotherapy ... Triple combination therapy in infants: Compelling evidence of the efficacy of early, aggressive therapy in neonates ... Risk factors and perinatal transmission: Data suggest that therapeutic strategies should emphasize reduction of viral load ... Oral ZDV may be equal to intravenous drug during delivery: Both achieve dramatic reductions in perinatal transmission rates ... Low-dose ZDV is effective in children: Optimal dose appears to be 90 mg/m2
or less ... Glaxo Wellcome makes its promising new nucleoside analog, abacavir (GW1592), available to children as well as adults ...
PULL OUT AND SAVE
Highlights of a task force report aimed at optimizing maternal health and reducing perinatal transmission of HIV infection
The pediatric standard of care -- especially with regard to the use of protease inhibitors -- is a crazy quilt of guesswork and hopeful comparisons
PHILIP TOLTZIS, M.D., AND TIFFANI COLEMAN, R.N., N.D.
This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline.